Mechanistic role of RND3-regulated IL33/ST2 signaling on cardiomyocyte senescence
- 7 May 2024
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 348, 122701
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Natural Science Foundation of China
- Key Research and Development Project of Hainan Province
This publication has 43 references indexed in Scilit:
- Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokineCytokine, 2022
- IL-33 in the basolateral amygdala integrates neuroinflammation into anxiogenic circuits via modulating BDNF expressionBrain, Behavior, and Immunity, 2022
- RND3 attenuates oxidative stress and vascular remodeling in spontaneously hypertensive rat via inhibiting ROCK1 signalingRedox Biology, 2021
- Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse ModelHepatology, 2021
- Interleukin‐33 alleviates diabetic cardiomyopathy through regulation of endoplasmic reticulum stress and autophagy via insulin‐like growth factor‐binding protein 3Journal of Cellular Physiology, 2020
- Soluble ST2: A complex and diverse role in several diseasesClinica Chimica Acta, 2020
- sST2 as a value-added biomarker in heart failureClinica Chimica Acta, 2020
- The methylation of nuclear and mitochondrial DNA in ageing phenotypes and longevityMechanisms of Ageing and Development, 2017
- Inflammatory mechanisms in patients with chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2016
- Pathophysiological Functions of Rnd 3/ RhoE2015